Next Article in Journal
Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma
Previous Article in Journal
Neoadjuvant Therapy in Lung Cancer: What Is Most Important: Objective Response Rate or Major Pathological Response?
Review

Article Versions Notes

Curr. Oncol. 2021, 28(5), 4139-4156; https://doi.org/10.3390/curroncol28050351
Action Date Notes Link
article xml file uploaded 13 October 2021 22:40 CEST Update https://www.mdpi.com/1718-7729/28/5/351/xml
article xml uploaded. 13 October 2021 22:40 CEST Update https://www.mdpi.com/1718-7729/28/5/351/xml
article pdf uploaded. 13 October 2021 22:40 CEST Updated version of record https://www.mdpi.com/1718-7729/28/5/351/pdf
article html file updated 13 October 2021 22:42 CEST Update https://www.mdpi.com/1718-7729/28/5/351/html
Back to TopTop